Skip to main content

Radiation-Induced Sarcoma

  • Chapter
  • First Online:
  • 1518 Accesses

Abstract

One of the few known causes of sarcomas is therapeutic irradiation. Therapeutic radiation has also been associated with development of breast cancer, lung cancer, and accelerated coronary artery disease in patients receiving thoracic radiation [1–3]. With the increased recognition of second cancers as a long-term side effect of radiation therapy, attempts have been made to use radiation more sparingly. For example, there is a question as to whether surgery for ductal carcinoma in situ is necessary, whereas at least one present standard of care is lumpectomy and radiation therapy, despite the ability to obtain negative margins in at least 95 % of patients with surgery alone, and no difference in long-term breast cancer mortality with the addition of radiation therapy [4, 5]. The incidence of a sarcoma after radiation is not precisely known, and may vary from one part of the body to the next. In a series of patients treated for cancer of all sites in Finland, for example, the crude risk was of the order of 0.05 % [6].

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Friedman DL, Whitton J, Leisenring W, et al. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2010;102:1083–95.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355:1572–82.

    Article  CAS  PubMed  Google Scholar 

  3. Dineen SP, Roland CL, Feig R, et al. Radiation-associated undifferentiated pleomorphic sarcoma is associated with worse clinical outcomes than sporadic lesions. Ann Surg Oncol. 2015;22(12):3913–20.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Motwani SB, Goyal S, Moran MS, et al. Ductal carcinoma in situ treated with breast-conserving surgery and radiotherapy: a comparison with ECOG study 5194. Cancer. 2011;117:1156–62.

    Article  PubMed  Google Scholar 

  5. Virnig BA, Tuttle TM, Shamliyan T, et al. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst. 2010;102:170–8.

    Article  PubMed  Google Scholar 

  6. Virtanen A, Pukkala E, Auvinen A. Incidence of bone and soft tissue sarcoma after radiotherapy: a cohort study of 295,712 Finnish cancer patients. Int J Cancer. 2006;118:1017–21.

    Article  CAS  PubMed  Google Scholar 

  7. Gladdy RA, Qin LX, Moraco N, et al. Do radiation-associated soft tissue sarcomas have the same prognosis as sporadic soft tissue sarcomas? J Clin Oncol. 2010;28:2064–9.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Bjerkehagen B, Smeland S, Walberg L, et al. Radiation-induced sarcoma: 25-year experience from the Norwegian Radium Hospital. Acta Oncol. 2008;47:1475–82.

    Article  CAS  PubMed  Google Scholar 

  9. Riad S, Biau D, Holt GE, et al. The clinical and functional outcome for patients with radiation-induced soft tissue sarcoma. Cancer. 2012;118:2682–92.

    Article  PubMed  Google Scholar 

  10. Bjerkehagen B, Smastuen MC, Hall KS, et al. Why do patients with radiation-induced sarcomas have a poor sarcoma-related survival? Br J Cancer. 2012;106:297–306.

    Article  CAS  PubMed  Google Scholar 

  11. Maki RG, D’Adamo DR, Keohan ML, et al. Phase II study of sorafenib in patients with metastatic or recurrent sarcomas. J Clin Oncol. 2009;27:3133–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Antonescu CR, Yoshida A, Guo T, et al. KDR activating mutations in human angiosarcomas are sensitive to specific kinase inhibitors. Cancer Res. 2009;69:7175–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Bonvalot S, Rimareix F, Causeret S, et al. Hyperthermic isolated limb perfusion in locally advanced soft tissue sarcoma and progressive desmoid-type fibromatosis with TNF 1 mg and melphalan (T1-M HILP) is safe and efficient. Ann Surg Oncol. 2009;16:3350–7.

    Article  PubMed  Google Scholar 

  14. Tawbi HA-H, Burgess MA, Crowley J, et al. Safety and efficacy of PD-1 blockade using pembrolizumab in patients with advanced soft tissue (STS) and bone sarcomas (BS): results of SARC028—a multicenter phase II study. In: ASCO meeting abstracts. 2016;34:11006.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Brennan, M.F., Antonescu, C.R., Alektiar, K.M., Maki, R.G. (2016). Radiation-Induced Sarcoma. In: Management of Soft Tissue Sarcoma. Springer, Cham. https://doi.org/10.1007/978-3-319-41906-0_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-41906-0_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-41904-6

  • Online ISBN: 978-3-319-41906-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics